# Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies

> **NCT01355822** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Jena** · enrollment: 111 (actual)

## Conditions studied

- High Risk Pregnancy

## Interventions

- **DRUG:** PETN
- **DRUG:** Placebo control

## Key facts

- **NCT ID:** NCT01355822
- **Lead sponsor:** University of Jena
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2008-01
- **Final completion:** —
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2011-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355822, "Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01355822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*